NC
ACAD icon

NinePointTwo Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

NinePointTwo Capital’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,702
Closed -$265K – 258
2022
Q4 		$265K Buy
+16,702
New +$265K 0.11% 48